Guardian Capital Advisors (Canada)’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-2,750
Closed -$246K 170
2018
Q1
$246K Buy
2,750
+500
+22% +$48K 0.03% 146
2017
Q4
$231K Buy
+2,250
New +$254K 0.03% 150
2017
Q3
Sell
-1,700
Closed -$229K 168
2017
Q2
$229K Hold
1,700
0.03% 146
2017
Q1
$211K Buy
+1,700
New +$203K 0.03% 156
2016
Q4
Sell
-3,473
Closed -$338K 177
2016
Q3
$338K Sell
3,473
-452
-12% -$48.9K 0.06% 125
2016
Q2
$386K Buy
3,925
+250
+7% +$25.9K 0.07% 121
2016
Q1
$372K Buy
3,675
+100
+3% +$10.3K 0.07% 122
2015
Q4
$402K Buy
3,575
+300
+9% +$34.7K 0.08% 124
2015
Q3
$356K Buy
3,275
+725
+28% +$90K 0.07% 128
2015
Q2
$303K Buy
2,550
+150
+6% +$17.1K 0.06% 144
2015
Q1
$324K Buy
+2,400
New +$287K 0.05% 157

Other funds holding CELG

Guardian Capital Advisors (Canada)'s CELG Position: Q2 2018 in Review

Guardian Capital Advisors (Canada) sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 2,750 shares — an estimated $246K sold.

Guardian Capital Advisors (Canada) first reported a position in CELG in Q1 2015 and held it in 11 quarters. The position peaked at $402K in Q4 2015. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Guardian Capital Advisors (Canada) reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Guardian Capital Advisors (Canada) sold 2,750 Celgene Corp shares in Q2 2018, an estimated $246K.
  • Guardian Capital Advisors (Canada) first reported a position in Celgene Corp in Q1 2015 and held it in 11 quarters.
  • Guardian Capital Advisors (Canada)'s Celgene Corp position peaked at $402K in Q4 2015.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Guardian Capital Advisors (Canada)'s 13F filing for Q2 2018, filed 14 Aug 2018.